March 17th, 2014
LOS ANGELES, March 17, 2014. Verde Media Group Inc. (OTC:VMGI) through it's Verde Media Biotechnology Division ("VMBD") announces the addition of cutting edge microbial technology program to produce cannabis-based phytocannabinoids products, including delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). The VMBD team will use the tool of metabolic engineering to transfer cannabis genetic pathways in microbes representing an alternative route to produce cannabinoids at an affordable and scalable manner.
The wide spread use of cannabis based medicines in diseases such as multiple sclerosis, chronic pain and many others requires large scale production of cannabinoids. VMBD and its novel approach will complement, traditional greenhouse based production of plant material, for rapid commercialization of active and derivative chemicals for both medical and recreational use. Furthermore, microbial based cannabinoids are uniform and specific in composition which is critical in medicinal usage and overcomes diverse pharmacological activities otherwise associated with different varieties or strains of plant materials.
Dr. Abidi, Ph.D. CEO of VMBD stated, "The microbial technology to produce key active cannabinoid molecules adds to our growing platform technologies for mass production and extraction of marijuana oils. We believe the alternative microbial production route can reduce THC/CBD cost by ten times or more adding to our competitive advantage in the industry. Our deep domain expertise in metabolic engineering and purification will allow rapid commercialization of cannabinoid based products in a fast growing market."
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI. Verde Media Group Inc. The company is consists of three divisions:
Agency Division- The innovative Agency division services- public relations, marketing, and transaction functions for corporate clientele. The agency is rapidly expanding its business in the Denver, Colorado market that will become the largest retail marijuana sector currently legitimized.
BioTech Division- The VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock. VMBD will further develop the derivative and ester forms of THC for increase potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.
| 
(0)
(0)